Axogen, Inc. — Director's Dealing 2015

Mar 17, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2015-03-12

Reporting Person: MCCARREY SHAWN F (SVP of Sales)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-12	Employee Stock Option (right to buy)	$3.20	A	120000	Acquired	2022-03-13	Common Stock (120000)	Direct

Footnotes

F1: The 120,000 shares are employee stock options with quarterly vesting of up to 12.5% of the total options granted in the event certain quarterly revenue goals are exceeded. Shares that do not vest in a quarter are no longer subject to future vesting. Vesting will be over a two year period from the grant date.